KINEPOLIS (KIN.BR) Fundamental Analysis & Valuation

EBR:KIN • BE0974274061

Current stock price

25.85 EUR
-0.1 (-0.39%)
Last:

This KIN.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. KIN.BR Profitability Analysis

1.1 Basic Checks

  • KIN had positive earnings in the past year.
  • KIN had a positive operating cash flow in the past year.
  • KIN had positive earnings in 4 of the past 5 years.
  • In the past 5 years KIN always reported a positive cash flow from operatings.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of KIN (3.99%) is better than 71.11% of its industry peers.
  • The Return On Equity of KIN (19.38%) is better than 80.00% of its industry peers.
  • KIN has a Return On Invested Capital of 9.92%. This is in the better half of the industry: KIN outperforms 77.78% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 19.38%
ROIC 9.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With a decent Profit Margin value of 5.45%, KIN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of KIN has grown nicely.
  • Looking at the Operating Margin, with a value of 12.02%, KIN is in the better half of the industry, outperforming 71.11% of the companies in the same industry.
  • KIN's Operating Margin has improved in the last couple of years.
  • KIN's Gross Margin of 21.80% is on the low side compared to the rest of the industry. KIN is outperformed by 84.44% of its industry peers.
  • KIN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.02%
PM (TTM) 5.45%
GM 21.8%
OM growth 3Y1.62%
OM growth 5YN/A
PM growth 3Y6.79%
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5YN/A
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. KIN.BR Health Analysis

2.1 Basic Checks

  • KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • KIN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • KIN has an Altman-Z score of 1.59. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
  • KIN has a better Altman-Z score (1.59) than 66.67% of its industry peers.
  • KIN has a debt to FCF ratio of 7.85. This is a slightly negative value and a sign of low solvency as KIN would need 7.85 years to pay back of all of its debts.
  • KIN has a Debt to FCF ratio (7.85) which is in line with its industry peers.
  • KIN has a Debt/Equity ratio of 2.10. This is a high value indicating a heavy dependency on external financing.
  • KIN has a worse Debt to Equity ratio (2.10) than 64.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 7.85
Altman-Z 1.59
ROIC/WACC1.45
WACC6.86%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • KIN has a Current Ratio of 0.55. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.55, KIN is doing worse than 68.89% of the companies in the same industry.
  • A Quick Ratio of 0.53 indicates that KIN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.53, KIN is doing worse than 71.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.53
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. KIN.BR Growth Analysis

3.1 Past

  • KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.95%, which is quite good.
  • Measured over the past years, KIN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.02% on average per year.
  • The Revenue has grown by 42.30% in the past year. This is a very strong growth!
  • Measured over the past years, KIN shows a very strong growth in Revenue. The Revenue has been growing by 26.23% on average per year.
EPS 1Y (TTM)13.95%
EPS 3Y12.02%
EPS 5YN/A
EPS Q2Q%-2.81%
Revenue 1Y (TTM)42.3%
Revenue growth 3Y4.16%
Revenue growth 5Y26.23%
Sales Q2Q%68.42%

3.2 Future

  • KIN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.40% yearly.
  • The Revenue is expected to grow by 7.29% on average over the next years.
EPS Next Y43.44%
EPS Next 2Y27.47%
EPS Next 3Y24.4%
EPS Next 5YN/A
Revenue Next Year20.41%
Revenue Next 2Y12.88%
Revenue Next 3Y8.17%
Revenue Next 5Y7.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. KIN.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 15.48, the valuation of KIN can be described as correct.
  • 84.44% of the companies in the same industry are more expensive than KIN, based on the Price/Earnings ratio.
  • KIN is valuated rather cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 10.57 indicates a reasonable valuation of KIN.
  • Based on the Price/Forward Earnings ratio, KIN is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 22.51. KIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.48
Fwd PE 10.57
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • KIN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. KIN is cheaper than 71.11% of the companies in the same industry.
  • KIN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KIN is cheaper than 82.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.47
EV/EBITDA 7.26
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • KIN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as KIN's earnings are expected to grow with 24.40% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y27.47%
EPS Next 3Y24.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. KIN.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.84%, KIN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.06, KIN pays a bit more dividend than its industry peers.
  • KIN's Dividend Yield is comparable with the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 1.84%

5.2 History

  • The dividend of KIN decreases each year by -3.24%.
Dividend Growth(5Y)-3.24%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • KIN pays out 32.78% of its income as dividend. This is a sustainable payout ratio.
DP32.78%
EPS Next 2Y27.47%
EPS Next 3Y24.4%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

KIN.BR Fundamentals: All Metrics, Ratios and Statistics

KINEPOLIS

EBR:KIN (3/26/2026, 7:00:00 PM)

25.85

-0.1 (-0.39%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20
Earnings (Next)N/A
Inst Owners16.13%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap707.51M
Revenue(TTM)822.78M
Net Income(TTM)44.88M
Analysts86
Price Target45.78 (77.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.84%
Yearly Dividend0.55
Dividend Growth(5Y)-3.24%
DP32.78%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.46%
PT rev (3m)-7.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.86%
EPS NY rev (3m)-8.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 15.48
Fwd PE 10.57
P/S 0.86
P/FCF 7.47
P/OCF 5.1
P/B 3.05
P/tB 13.38
EV/EBITDA 7.26
EPS(TTM)1.67
EY6.46%
EPS(NY)2.45
Fwd EY9.46%
FCF(TTM)3.46
FCFY13.39%
OCF(TTM)5.07
OCFY19.6%
SpS30.06
BVpS8.46
TBVpS1.93
PEG (NY)0.36
PEG (5Y)N/A
Graham Number17.83
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 19.38%
ROCE 13.36%
ROIC 9.92%
ROICexc 12.41%
ROICexgc 17.78%
OM 12.02%
PM (TTM) 5.45%
GM 21.8%
FCFM 11.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.62%
OM growth 5YN/A
PM growth 3Y6.79%
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5YN/A
F-Score7
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 7.85
Debt/EBITDA 2.71
Cap/Depr 54.31%
Cap/Sales 5.34%
Interest Coverage 4.68
Cash Conversion 77.15%
Profit Quality 211.16%
Current Ratio 0.55
Quick Ratio 0.53
Altman-Z 1.59
F-Score7
WACC6.86%
ROIC/WACC1.45
Cap/Depr(3y)49.94%
Cap/Depr(5y)40.94%
Cap/Sales(3y)7.03%
Cap/Sales(5y)6.61%
Profit Quality(3y)253.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y12.02%
EPS 5YN/A
EPS Q2Q%-2.81%
EPS Next Y43.44%
EPS Next 2Y27.47%
EPS Next 3Y24.4%
EPS Next 5YN/A
Revenue 1Y (TTM)42.3%
Revenue growth 3Y4.16%
Revenue growth 5Y26.23%
Sales Q2Q%68.42%
Revenue Next Year20.41%
Revenue Next 2Y12.88%
Revenue Next 3Y8.17%
Revenue Next 5Y7.29%
EBIT growth 1Y20.48%
EBIT growth 3Y5.85%
EBIT growth 5YN/A
EBIT Next Year129.3%
EBIT Next 3Y39.36%
EBIT Next 5Y22.96%
FCF growth 1Y-21.7%
FCF growth 3Y-4.34%
FCF growth 5YN/A
OCF growth 1Y-15.27%
OCF growth 3Y0.65%
OCF growth 5YN/A

KINEPOLIS / KIN.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 5 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 8 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 6 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 15.48 and the Price/Book (PB) ratio is 3.05.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 4 / 10 and the dividend payout ratio is 32.78%.